Illumina | ILMN - Loan Capital



Illumina reported $1.49B in Loan Capital for its fiscal quarter ending in June of 2025.


Loan Capital Change Date
Agilent USD 3.35B 1000K Jul/2025
Bio Techne USD 346M 16M Jun/2025
Bio-Rad Laboratories USD 1.2B 400K Jun/2025
Boston Scientific USD 10.53B 1.56B Mar/2025
Bruker USD 2.38B 303.5M Jun/2025
Charles River Laboratories USD 2.33B 178.38M Jun/2025
Danaher USD 16.85B 877M Jun/2025
Dentsply International USD 2.22B 625M Jun/2025
Edwards Lifesciences USD 597.8M 100K Mar/2025
Exact Sciences USD 2.32B 9.48M Jun/2025
Hologic USD 2.51B 37.5M Jun/2025
Illumina USD 1.49B 1000K Jun/2025
Intuitive Surgical USD 0 0 Mar/2025
IQVIA Holdings USD 14.18B 1.07B Jun/2025
Laboratory Of America USD 5.14B 425.8M Jun/2025
Mettler Toledo International USD 2.12B 232.49M Jun/2025
Myriad Genetics USD 59.3M 19.7M Mar/2025
Quest Diagnostics USD 5.17B 689M Jun/2025
Quidel USD 2.07B 33.8M Jun/2025
Repligen USD 533.72M 4.12M Jun/2025
Revvity USD 3.21B 45.94M Jun/2025
Roche Holding CHF 32.1B 1.94B Dec/2024
Standard Biotools USD 299K 0 Jun/2025
Thermo Fisher Scientific USD 33.02B 1.64B Jun/2025
Waters USD 1.2B 159.76M Jun/2025